The treatment for hypertrophic cardiomyopathy (HCM) depends on the severity of of the muscle thickening in your heart, the presence or absence of outflow tract obstruction, and what your care team determined your risks to be.
Please visit Hypertrophic Cardiomyopathy Association (HCMA)* for information about HCM.
By clicking on these websites, you are leaving the Northwestern Medicine website. These websites are independent resources. Northwestern Medicine does not operate or control the content of these websites. By visiting these websites, you agree to this third party’s terms of use for their website.
Looking for a Second Opinion?
It's vital that you're comfortable with your treatment decision and have confidence in your doctor. For these reasons, a second opinion with another specialist can help you make smart treatment decisions.
Know Your Risk
Use these health assessment tools to understand your risk for:
Chrome
Edge
Safari
Firefox